NEW YORK (360Dx) – MBio Diagnostics today announced it has been awarded a Phase II contract from the US Defense Advanced Research Projects Agency for the further development of a portable multiplexed immunoassay system.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.